Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2021-2027

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Perspective (2016-2027)
2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions
2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Age-Related Macular Degeneration (AMD) Therapeutics Industry Dynamic
2.3.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Trends
2.3.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Drivers
2.3.3 Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
2.3.4 Age-Related Macular Degeneration (AMD) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Revenue
3.1.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
3.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio
3.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2020
3.5 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served
3.6 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
3.7 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Type
4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2022-2027)
5 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Application
5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2016-2027)
6.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
6.2.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2027)
6.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
6.3.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2027)
6.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
6.4.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2016-2027)
7.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
7.2.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
7.3.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
7.4.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2016-2027)
9.2 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
9.2.1 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
9.3.1 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
9.4.1 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 Bausch Health Companies, Inc.
11.2.1 Bausch Health Companies, Inc. Company Details
11.2.2 Bausch Health Companies, Inc. Business Overview
11.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
11.2.5 Bausch Health Companies, Inc. Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Regeneron Pharmaceuticals Inc.
11.5.1 Regeneron Pharmaceuticals Inc. Company Details
11.5.2 Regeneron Pharmaceuticals Inc. Business Overview
11.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
11.5.5 Regeneron Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2022-2027)
Table 10. Age-Related Macular Degeneration (AMD) Therapeutics Market Trends
Table 11. Age-Related Macular Degeneration (AMD) Therapeutics Market Drivers
Table 12. Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
Table 13. Age-Related Macular Degeneration (AMD) Therapeutics Market Restraints
Table 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2020)
Table 17. Ranking of Global Top Age-Related Macular Degeneration (AMD) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
Table 21. Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Amgen Inc. Company Details
Table 62. Amgen Inc. Business Overview
Table 63. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product
Table 64. Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Amgen Inc. Recent Development
Table 66. Bausch Health Companies, Inc. Company Details
Table 67. Bausch Health Companies, Inc. Business Overview
Table 68. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product
Table 69. Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bausch Health Companies, Inc. Recent Development
Table 71. F. Hoffmann-La Roche Ltd. Company Details
Table 72. F. Hoffmann-La Roche Ltd. Business Overview
Table 73. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product
Table 74. F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Ltd. Recent Development
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product
Table 79. Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. Regeneron Pharmaceuticals Inc. Company Details
Table 82. Regeneron Pharmaceuticals Inc. Business Overview
Table 83. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product
Table 84. Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Regeneron Pharmaceuticals Inc. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institute Case Studies
Figure 8. Other Case Studies
Figure 9. Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered
Figure 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players in 2020
Figure 15. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2020
Figure 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Region (2016-2027)
Figure 39. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Amgen Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
Figure 59. Bausch Health Companies, Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
Figure 60. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
Figure 62. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs